[
    [
        {
            "time": "",
            "original_text": "上海医药与俄罗斯BIOCAD公司签署合作备忘：拟引进四款生物仿制药、两款生物创新药",
            "features": {
                "keywords": [
                    "上海医药",
                    "俄罗斯BIOCAD",
                    "合作备忘",
                    "生物仿制药",
                    "生物创新药"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上海医药与俄罗斯BIOCAD公司签署合作备忘：拟引进四款生物仿制药、两款生物创新药",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "仿制药概念遭遇重挫 消息称第一批带量采购清单公布",
            "features": {
                "keywords": [
                    "仿制药",
                    "重挫",
                    "带量采购",
                    "清单公布"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "仿制药概念遭遇重挫 消息称第一批带量采购清单公布",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药板块表现疲软 恩华药业跌停",
            "features": {
                "keywords": [
                    "医药板块",
                    "疲软",
                    "恩华药业",
                    "跌停"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药板块表现疲软 恩华药业跌停",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]